A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study)
Completed · Phase 3
Conditions studied: Bleeding
In brief
The purpose of this study was to evaluate the hemostatic efficacy of andexanet alfa (andexanet) in participants receiving a factor Xa (FXa) inhibitor (apixaban, rivaroxaban, edoxaban, enoxaparin) who were experiencing an acute major bleed. The safety of andexanet was also studied.
Key facts
- Study ID
- NCT02329327
- Run by
- Alexion Pharmaceuticals, Inc.
- People needed
- 479
- Starts
- 2015-04-10
- Expected to finish
- 2020-09-24
- Last updated by the study team
- 2022-02-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Study Site — Los Angeles, California, United States
- Clinical Study Site — Orange, California, United States
- Clinical Study Site — Fort Lauderdale, Florida, United States
- Clinical Study Site — Jacksonville, Florida, United States
- Clinical Study Site — Sarasota, Florida, United States
- Clinical Study Site — Tampa, Florida, United States
- Clinical Study Site — Annapolis, Maryland, United States
- Clinical Study Site — Boston, Massachusetts, United States
- Clinical Study Site — Detroit, Michigan, United States
- Clinical Study Site — Royal Oak, Michigan, United States
- Clinical Study Site — Troy, Michigan, United States
- Clinical Study Site — St Louis, Missouri, United States
- Clinical Study Site — Rochester, New York, United States
- Clinical Study Site — Asheville, North Carolina, United States
- Clinical Study Site — Chapel Hill, North Carolina, United States
- Clinical Study Site — Raleigh, North Carolina, United States
- Clinical Study Site — Cincinnati, Ohio, United States
- Clinical Study Site — Cleveland, Ohio, United States
- Clinical Study Site — Pittsburgh, Pennsylvania, United States
- Clinical Study Site — Austin, Texas, United States
- Clinical Study Site — Fort Worth, Texas, United States
- Clinical Study Site — Huntington, West Virginia, United States
- Clinical Study Site — Brussels, Belgium
- Clinical Study Site — Genk, Belgium
- Clinical Study Site — Long Beach, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.